Iasis Molecular Sciences, Inc. is an antimicrobial solutions company developing and implementing novel strategies aimed at preventing the spread of surface-transmittable infectious disease, particularly device-related and healthcare-associated infections (HAIs). These crossover solutions can be added with ease to synthetic materials to impart self-disinfecting capabilities and have application in medical, advanced coatings, consumer, textile, and industrial markets.
| Website | http://www.iasismolecular.com |
| Revenue | $7.4 million |
| Employees | 4 (2 on RocketReach) |
| Founded | 2008 |
| Address | 120 N. Pine St. Suite # 279, Spokane, Washington 99202, US |
| Phone | +1 509-290-6873 |
| Technologies |
JavaScript
,
HTML
,
PHP
+10 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering |
| Keywords | Microbial Control, Antimicrobial Solutions, Antimicrobial Research, Infection Prevention, Healthcare Infection Control, Infection Control Products, Surface Disinfection, Antimicrobial Technology, Disinfection Technology, Infection Control Technology, Healthcare-Associated Infections, Antimicrobial Coatings, Preventative Healthcare, Biosafety, Sterilization Solutions, Hygiene Solutions |
Looking for a particular Iasis Molecular Sciences, Inc. employee's phone or email?
The Iasis Molecular Sciences, Inc. annual revenue was $7.4 million in 2026.
Mark Vachon is the VP, Quality, Iasis Molecular Sciences of Iasis Molecular Sciences, Inc..
2 people are employed at Iasis Molecular Sciences, Inc..
Iasis Molecular Sciences, Inc. is based in Spokane, Washington.